• iShares U.S. Medical Devices ETF

iShares

  • US
  • Health/Biotechnology
  • Recently Viewed
  • Symbol Price
    FNGO 53.69
    FLLA 99.12
    DFVS 12.19
    CUT 25.08
    IUSS 17.79
    NFTY 29.37
    ESPO 28.21
    GULF 20.75
    CORP 103.74
    RZG 116.09

iShares U.S. Medical Devices ETF

IHI

Summary

The fund seeks to replicate the total return performance of the benchmark index before fees and expenses by investing in companies across any size in the United States.

The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.

As part of its strategy, the fund employs a passive or indexing approach.

Next, the research team invests significantly in the component securities of its Underlying Index and in investments that have economic characteristics that are substantially identical to the component securities of its Underlying Index.

The Underlying Index includes medical equipment companies, including manufacturers and distributors of medical devices such as magnetic resonance imaging (MRI) scanners, prosthetics, pacemakers, Xray machines, and other non-disposable medical devices.

The team utilizes a representative sampling indexing strategy to evaluate companies based on market capitalization and industry weightings.

In addition, the team also assesses a company’s return variability and yield and liquidity characteristics.

Then the manager constructs a portfolio of stocks from a list of companies favored by the research team and allocates capital based on its conviction level.

The fund may or may not hold all of the securities in the Underlying Index.

Additionally, the fund may lend securities representing up to one-third of the value of the fund’s net assets.

The fund will concentrate its investments in a particular industry or group of industries to approximately the same extent that the Underlying Index is concentrated.

Also, the fund may invest in certain futures, options and swap contracts, cash and cash equivalents.

Price

Last Close

$ 66.07 ( +0.6 )

52 Week HL

$67.18 - $47.35

Net Assets

Expense Ratio

Performance

- YTD

3 Year

-66.93%

5 Year

-54.36%

Best

38.5% 2009

Worst

-79.86% 2021

Returns +
Q

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Q1 - -14.3% 15.9% 6.6% 13.8% 0% 6.4% 6.6% 13.2% 15.5% -
Q2 - 17.5% 4.2% 11.2% 10.1% 10.8% -0.3% 3.5% 3.5% -3.3% -
Q3 - 13.2% 1.9% 13.1% 0.4% 7.4% -6.9% -2.4% 7% 3.7% -
Q4 - 9.2% 6.3% -12.1% 3.2% -8.2% 11% 14.1% 9.8% -1.5% -

Returns +
M

J F M A M J J A S O N D
2021 - - - - - - - - - - - -
2020 -19.16% -10.67% -4.67% 14.24% 4.3% -1.39% 10.68% 3.58% -1.29% -0.49% 5.02% 4.53%

Returns +

    2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
    0%16%29%-6%19%8%-1%14%29%13%0%

Alpha IHI and S&P 500

IHI and S&P 500

Chart +